Classification Term: 3327

Biphenyls and derivatives (ontology term: CHEMONTID:0000041)

Organic compounds containing to benzene rings linked together by a C-C bond." []

found 113 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Ancestor: Benzene and substituted derivatives

Child Taxonomies: Brominated biphenyls, Chlorinated biphenyls, Biphenylcarbonitriles, Benzidines

Candesartan

2-ethoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid

C24H20N6O3 (440.159681)


Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is administered orally as the prodrug, candesartan cilexetil, which is rapidly converted to its active metabolite, candesartan, during absorption in the gastrointestinal tract. Candesartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Candesartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 79 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2804 CONFIDENCE standard compound; INTERNAL_ID 2137 CONFIDENCE standard compound; INTERNAL_ID 8182 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3]. Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3].

   

Irbesartan

2-butyl-3-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-diazaspiro[4.4]non-1-en-4-one

C25H28N6O (428.2324478)


Irbesartan is an angiotensin receptor blocker (ARB) used mainly for the treatment of hypertension. It competes with angiotensin II for binding at the AT1 receptor subtype. Unlike ACE inhibitors, ARBs do not have the adverse effect of dry cough. The use of ARBs is pending revision due to findings from several clinical trials suggesting that this class of drugs may be associated with a small increased risk of cancer. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2774 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Irbesartan (SR-47436) is an orally active Ang II type 1 (AT1) receptor blocker (ARB). Irbesartan can relax the blood vessels, low blood pressure and increase the supply of blood and oxygen to the heart. Irbesartan can be used for the research of high blood pressure, heart failure, and diabetic kidney disease[1].

   

Telmisartan

2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid

C33H30N4O2 (514.236864)


Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension. Generally, angiotensin II receptor blockers (ARBs) such as telmisartan bind to the angiotensin II type 1 (AT1) receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial blood pressure. Recent studies suggest that telmisartan may also have PPAR-gamma agonistic properties that could potentially confer beneficial metabolic effects. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2805 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM.

   

4-Aminobiphenyl

[1,1-Biphenyl]-4-ylamine (acd/name 4.0)

C12H11N (169.0891446)


4-Aminobiphenyl is an amine derivative of biphenyl. It is used to manufacture azo dyes. It is a known human carcinogen and so it has been largely replaced by less toxic compounds. It is similar to benzidine. [HMDB] 4-Aminobiphenyl is an amine derivative of biphenyl. It is used to manufacture azo dyes. It is a known human carcinogen and so it has been largely replaced by less toxic compounds. It is similar to benzidine. D009676 - Noxae > D002273 - Carcinogens

   

2-Biphenylol

2-phenylphenate tetrahydrate

C12H10O (170.073161)


2-Biphenylol is found in lemon. It is an antifungal agent and preservative. 2-Biphenylol is used for post-harvest control of storage disease in apples, citrus fruit, stone fruit, tomatoes, cucumber and peppers through the use of impregnated wrapping materials or by direct application in a wax. 2-Biphenylol is used in food seasonings. Inhibitory to a wider range of moulds than Biphenyl HMJ12-A. The practical way of treatment is to immerse citrus fruit in an alkaline aqueous solution of the parent compound or its Na salt Antifungal agent, preservative. It is used for post-harvest control of storage disease in apples, citrus fruit, stone fruit, tomatoes, cucumber and peppers through the use of impregnated wrapping materials or by direct application in a wax. It is used in food seasonings. Inhibitory to a wider range of moulds than Biphenyl HMJ12-A. The practical way of treatment is to immerse citrus fruit in an alkaline aq. soln. of the parent compound or its Na salt. 2-Biphenylol is found in lemon. CONFIDENCE standard compound; INTERNAL_ID 1392; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9460; ORIGINAL_PRECURSOR_SCAN_NO 9456 CONFIDENCE standard compound; INTERNAL_ID 1392; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9365; ORIGINAL_PRECURSOR_SCAN_NO 9363 CONFIDENCE standard compound; INTERNAL_ID 1392; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9398; ORIGINAL_PRECURSOR_SCAN_NO 9393 CONFIDENCE standard compound; INTERNAL_ID 1392; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9460; ORIGINAL_PRECURSOR_SCAN_NO 9457 CONFIDENCE standard compound; INTERNAL_ID 1392; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9464; ORIGINAL_PRECURSOR_SCAN_NO 9459 CONFIDENCE standard compound; INTERNAL_ID 1392; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9412; ORIGINAL_PRECURSOR_SCAN_NO 9407 CONFIDENCE standard compound; INTERNAL_ID 970; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4368; ORIGINAL_PRECURSOR_SCAN_NO 4365 CONFIDENCE standard compound; INTERNAL_ID 970; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4893; ORIGINAL_PRECURSOR_SCAN_NO 4890 CONFIDENCE standard compound; INTERNAL_ID 970; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4862; ORIGINAL_PRECURSOR_SCAN_NO 4859 CONFIDENCE standard compound; INTERNAL_ID 970; DATASET 20200303_ENTACT_RP_MIX502; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4365; ORIGINAL_PRECURSOR_SCAN_NO 4361 CONFIDENCE standard compound; INTERNAL_ID 970; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4839; ORIGINAL_PRECURSOR_SCAN_NO 4835 CONFIDENCE standard compound; INTERNAL_ID 970; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4882; ORIGINAL_PRECURSOR_SCAN_NO 4877 D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AE - Phenol and derivatives D009676 - Noxae > D002273 - Carcinogens D000890 - Anti-Infective Agents D016573 - Agrochemicals D004202 - Disinfectants D010575 - Pesticides

   

Losartan

[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol

C22H23ClN6O (422.1621778)


Losartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. Losartan and its longer acting metabolite, E-3174, lower blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); they compete with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Losartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of systolic dysfunction, myocardial infarction, coronary artery disease, and heart failure. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 2794 CONFIDENCE standard compound; INTERNAL_ID 8189 CONFIDENCE standard compound; INTERNAL_ID 8607 CONFIDENCE standard compound; INTERNAL_ID 2280 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan is an angiotensin II receptor antagonist, competing with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.

   

Candesartan cilexetil

1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid

C33H34N6O6 (610.2539704000001)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].

   

Magnolol

2-[2-hydroxy-5-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol

C18H18O2 (266.1306728)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents Magnolol, a natural lignan isolated from the stem bark of Magnolia officinalis, is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively. Magnolol, a natural lignan isolated from the stem bark of Magnolia officinalis, is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively. Magnolol, a natural lignan isolated from the stem bark of Magnolia officinalis, is a dual agonist of both RXRα and PPARγ, with EC50 values of 10.4 μM and 17.7 μM, respectively.

   

Diflunisal

2,4-Difluoro-4-hydroxy-3-biphenylcarboxylic acid

C13H8F2O3 (250.0441482)


Diflunisal, a salicylate derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with pharmacologic actions similar to other prototypical NSAIAs. Diflunisal possesses anti-inflammatory, analgesic and antipyretic activity. Though its mechanism of action has not been clearly established, most of its actions appear to be associated with inhibition of prostaglandin synthesis via the arachidonic acid pathway. Diflunisal is used to relieve pain accompanied with inflammation and in the symptomatic treatment of rheumatoid arthritis and osteoarthritis. N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BA - Salicylic acid and derivatives D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D004791 - Enzyme Inhibitors KEIO_ID D058

   

Flurbiprofen

(±)-2-fluoro-α-methyl-[1,1-biphenyl]-4-acetic acid

C15H13FO2 (244.089953)


Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AE - Propionic acid derivatives S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

Olmesartan

4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylic acid

C24H26N6O3 (446.20662860000004)


Olmesartan is an antihypertensive agent which belongs to the class of medicines called angiotensin II receptor antagonists. It acts rapidly to lower high blood pressure. It is marketed worldwide by Daiichi Sankyo, Ltd. and in the United States by Daiichi Sankyo, Inc. and Forest Laboratories. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Olmesartan (RNH-6270) is an angiotensin II receptor (AT1R) antagonist used to treat high blood pressure[1][2].

   

Honokiol

2-[4-hydroxy-3-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol

C18H18O2 (266.1306728)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D005765 - Gastrointestinal Agents D000890 - Anti-Infective Agents D000970 - Antineoplastic Agents D018926 - Anti-Allergic Agents D004791 - Enzyme Inhibitors Honokiol is a bioactive, biphenolic phytochemical that possesses potent antioxidative, anti-inflammatory, antiangiogenic, and anticancer activities by targeting a variety of signaling molecules. It inhibits the activation of Akt. Honokiol can readily cross the blood brain barrier[1][2][3][4]. Honokiol is a bioactive, biphenolic phytochemical that possesses potent antioxidative, anti-inflammatory, antiangiogenic, and anticancer activities by targeting a variety of signaling molecules. It inhibits the activation of Akt. Honokiol can readily cross the blood brain barrier[1][2][3][4]. Honokiol is a bioactive, biphenolic phytochemical that possesses potent antioxidative, anti-inflammatory, antiangiogenic, and anticancer activities by targeting a variety of signaling molecules. It inhibits the activation of Akt. Honokiol can readily cross the blood brain barrier[1][2][3][4].

   

Adenylsuccinic acid

(2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid

C14H18N5O11P (463.0740408)


Adenylsuccinic acid, also known as adenylosuccinate, succinyladenosine or aspartyl adenylate, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Adenylsuccinic acid is found in all living organisms, ranging from bacteria to plants to animals. Adenylsuccinic acid is an important intermediate in the de novo purine biosynthesis pathway. Specifically, adenylsuccinic acid is an intermediate in the interconversion of purine nucleotides inosine monophosphate (IMP) and adenosine monophosphate (AMP). The enzyme adenylosuccinate synthase carries out the reaction by the addition of aspartate to IMP. This reaction requires the input of energy from a phosphoanhydride bond in the form of guanosine triphosphate (GTP). Adenylsuccinic acid is a substrate least one other important metabolic reaction in purine biosynthesis. In particular, adenylsuccinic acid can be converted into fumaric acid through its interaction with the enzyme known as adenylosuccinate lyase (or adenylosuccinase). Adenylosuccinate lyase deficiency, is a rare autosomal recessive metabolic disorder characterized by the appearance of succinylaminoimidazolecarboxamide riboside (SAICA riboside) and adenylsuccinic acid in cerebrospinal fluid and urine (PMID: 8412002). Adenylosuccinate lyase deficiency presents with varying degrees of psychomotor retardation, autism, muscle wasting, and epilepsy. The exact cause of the symptoms is unknown, but possibilities include not enough purine nucleotide synthesis for cell replication, malfunctioning of the purine nucleotide cycle, and a buildup of substrates to toxic levels. Adenylsuccinic acid is a substrate of the enzyme adenylosuccinase [EC 4.3.2.2] in purine metabolism pathway. The accumulation of adenylsuccinic acid in body fluids occurs due to a deficiency of adenylosuccinase. (KEGG; PMID 8412002) [HMDB] D018377 - Neurotransmitter Agents > D018846 - Excitatory Amino Acids KEIO_ID A037; [MS2] KO008839 KEIO_ID A037; [MS3] KO008840 KEIO_ID A037

   

5-5'-Dehydrodiferulic acid

(2E)-3-(3-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxy-3-methoxyphenyl}-4-hydroxy-5-methoxyphenyl)prop-2-enoic acid

C20H18O8 (386.10016279999996)


5-5-dehydrodiferulic acid, also known as 8-O-4-diferulic acid, belongs to biphenyls and derivatives class of compounds. Those are organic compounds containing to benzene rings linked together by a C-C bond. 5-5-dehydrodiferulic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 5-5-dehydrodiferulic acid can be found in a number of food items such as corn, common wheat, semolina, and hard wheat, which makes 5-5-dehydrodiferulic acid a potential biomarker for the consumption of these food products.

   

N-hydroxy-4-aminobiphenyl

N-Hydroxy-4-aminobiphenyl

C12H11NO (185.0840596)


   

Biphenyl

Aromatic hydrocarbons, biphenyl-rich

C12H10 (154.078246)


Fungistat, especies for citrus fruits. It is used as food preservative and flavouring agent. Detected in bilberry, wine grape, carrot, peas, rum, potato, bell pepper, tomato, butter, milk, smoked fatty fish, cocoa, coffee, roast peanuts, olive, buckwheat and tamarind. Generally, the fruit packaging is impregnated with biphenyl, which evaporates into the air space surrounding the fruit. Some biphenyl is absorbed by the fruit skins. Biphenyl is found in many foods, some of which are lovage, carrot, alcoholic beverages, and nuts. Biphenyl is found in alcoholic beverages. Fungistat, especially for citrus fruits. Biphenyl is used as food preservative and flavouring agent. Biphenyl is detected in bilberry, wine grape, carrot, peas, rum, potato, bell pepper, tomato, butter, milk, smoked fatty fish, cocoa, coffee, roast peanuts, olive, buckwheat and tamarind. Generally, the fruit packaging is impregnated with biphenyl, which evaporates into the air space surrounding the fruit. Some biphenyl is absorbed by the fruit skin D016573 - Agrochemicals D010575 - Pesticides

   

Aucaparin

3,5-Dimethoxy-(1,1-biphenyl)-4-ol

C14H14O3 (230.0942894)


Aucuparin, also known as 3,5-dimethoxy-(1,1-biphenyl)-4-ol or 2,6-dimethoxy-4-phenylphenol, belongs to biphenyls and derivatives class of compounds. Those are organic compounds containing to benzene rings linked together by a C-C bond. Aucuparin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Aucuparin can be found in loquat and rowanberry, which makes aucuparin a potential biomarker for the consumption of these food products.

   

E-3174

2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylic acid

C22H21ClN6O2 (436.1414436)


EXP3174 is a metabolite of losartan (previous name DuP753), which is a non-peptide angiotensin II receptor antagonist. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells. (PMID: 8385175) D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents Losartan Carboxylic Acid (E-3174), an active carboxylic acid metabolite of Losartan, is an angiotensin II receptor type 1 (AT1) antagonist. The Ki values are 0.97, 0.57, 0.67 nM for rat AT1B/AT1A and human AT1, respectively. Losartan Carboxylic Acid blocks the angiotensin II-induced responses in vascular smoothmuscle cells (VSMC). Losartan Carboxylic Acid elevates plasma renin activities and reduces mean arterial pressure[1][2][3][4].

   

4-Methylbiphenyl

1-Methyl-4-phenylbenzene

C13H12 (168.0938952)


4-Methylbiphenyl is found in cocoa and cocoa products. 4-Methylbiphenyl is present in cocoa. 4-Methylbiphenyl is a flavouring ingredien Present in cocoa. Flavouring ingredient. 4-Methylbiphenyl is found in cocoa and cocoa products. 4-Methylbiphenyl is an endogenous metabolite.

   

Divanillin

3-(5-formyl-2-hydroxy-3-methoxyphenyl)-4-hydroxy-5-methoxybenzaldehyde

C16H14O6 (302.0790344)


Divanillin is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]")

   

Lepidine F

4-[2-hydroxy-5-(1H-imidazol-2-ylmethyl)phenyl]-3-(1H-imidazol-2-ylmethyl)phenol

C20H18N4O2 (346.14296879999995)


Alkaloid from the seeds of Lepidium sativum (garden cress). Lepidine F is found in garden cress and brassicas. Lepidine F is found in brassicas. Lepidine F is an alkaloid from the seeds of Lepidium sativum (garden cress).

   

4-O-8',5'-5'-Dehydrotriferulic acid

(2Z)-3-(3-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxy-3-methoxyphenyl}-4-hydroxy-5-methoxyphenyl)-2-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-methoxyphenoxy}prop-2-enoic acid

C30H26O12 (578.1424196)


4-O-8,5-5-Dehydrotriferulic acid is a polyphenol compound found in foods of plant origin (PMID: 20428313)

   

O-Deethylated candesartan

2-Hydroxy-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate

C22H16N6O3 (412.1283826)


O-Deethylated candesartan is only found in individuals that have used or taken Candesartan.O-Deethylated candesartan is a metabolite of Candesartan. O-deethylated candesartan belongs to the family of Biphenyltetrazoles and Derivatives. These are organic compounds containing a biphenyl attached to a tetrazole. A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety.

   

SR 49498

1-[(1-Hydroxypentylidene)amino]-N-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}cyclopentane-1-carboximidate

C25H30N6O2 (446.24301199999996)


SR 49498 is a metabolite of Irbesartan. Sr 49498 belongs to the family of Aromatic Homomonocyclic Compounds. These are aromatic compounds containig only one ring, which is homocyclic.

   

E-3179

2-butyl-4-chloro-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carbaldehyde

C22H21ClN6O (420.1465286)


E-3179 or Losartan carboxaldehyde is a CYP3A4 or CYP2C9 metabolite of Losartan. E-3179 belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. E-3179 is also classified as a biphenyltetrazole. E-3179 is a Losartan intermediate aldehyde that is eventually converted via CYP450 oxidation to Losartan carboxylate (E3174) which is pharmacologically more active than Losartan (PMID: 7736913). E-3179 is only found in individuals who have consumed the drug Losartan. Losartan is an angiotensin converting enzyme inhibitor used to treat hypertension.

   

Tasosartan

2,4-dimethyl-8-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-7-one

C23H21N7O (411.1807496)


Tasosartan is only found in individuals that have used or taken this drug. It is a long-acting angiotensin II (AngII) receptor blocker. Its long duration of action has been attributed to its active metabolite enoltasosartan. It is used to treat patients with essential hypertensionTasosartan is a selective, potent, orally active and long-acting nonpeptide Angiotensin II type 1 (AT1) receptor antagonist. Tasosartan blocks the renin-angiotensin-aldosterone system (RAAS) at the level of the AT1 receptor that mediates most, if not all, of the important actions of Ang II. Tasosartan binds reversibly to the AT1 receptors in vascular smooth muscle and the adrenal gland. As angiotensin II is a vasoconstrictor, which also stimulates the synthesis and release of aldosterone, blockage of its effects results in decreases in systemic vascular resistance. AT1 receptor antagonists avoid the nonspecificity of the Ang I converting enzyme (ACE) inhibitors. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers Tasosartan is a long-acting angiotensin II (AngII) receptor antagonist.

   

4'-Hydroxy-2-biphenylcarboxylic acid

4-HYDROXY-[1,1-BIPHENYL]-2-CARBOXYLIC ACID

C13H10O3 (214.062991)


4-Hydroxy-2-biphenylcarboxylic acid is found in green vegetables. 4-Hydroxy-2-biphenylcarboxylic acid is a constituent of Trifolium repens (white clover)

   

3,4',5-Biphenyltriol

5-(4-hydroxyphenyl)benzene-1,3-diol

C12H10O3 (202.062991)


Constituent of Trifolium repens (white clover). 3,4,5-Biphenyltriol is found in tea, herbs and spices, and green vegetables. 3,4,5-Biphenyltriol is found in green vegetables. 3,4,5-Biphenyltriol is a constituent of Trifolium repens (white clover).

   

2',4'-Dihydroxy-2-biphenylcarboxylic acid

2,4-Dihydroxy-[1,1-biphenyl]-2-carboxylate

C13H10O4 (230.057906)


2,4-Dihydroxy-2-biphenylcarboxylic acid is found in herbs and spices. 2,4-Dihydroxy-2-biphenylcarboxylic acid is a constituent of Trifolium repens (white clover) (isolated as the permethyl derivative). Constituent of Trifolium repens (white clover) (isol. as the permethyl deriv.). 2,4-Dihydroxy-2-biphenylcarboxylic acid is found in tea, herbs and spices, and pulses.

   

4'-Hydroxyflurbiprofen

2-[3-fluoro-4-(4-hydroxyphenyl)phenyl]propanoic acid

C15H13FO3 (260.08486800000003)


4-Hydroxyflurbiprofen is a metabolite of flurbiprofen. Flurbiprofen is a member of the phenylalkanoic acid derivative family of non-steroidal anti-inflammatory drugs (NSAIDs) used to treat the inflammation and pain of arthritis. It is known by the following tradenames: Urbifen marketed by General Pharmaceuticals, Ansaid, marketed by Pfizer, Flurwood by W. Woodward and Froben, by Abbott. Flurbiprofen is also used as an active ingredient in some kinds of throat lozenges. (Wikipedia)

   

(2-Methyl-3-phenyl-phenyl)methyl (3S)-3-[(Z)-2-chloro-3,3,3-trifluoro-prop-1-enyl]-2,2-dimethyl-cyclopropanecarboxylate

(2-Methyl-3-phenyl-phenyl)methyl (3S)-3-[(Z)-2-chloro-3,3,3-trifluoro-prop-1-enyl]-2,2-dimethyl-cyclopropanecarboxylic acid

C23H22ClF3O2 (422.1260338)


   

(Imidazolylbiphenylyl)sulfonylurea

{[3-(1H-imidazol-2-yl)-[1,1-biphenyl]-2-yl]sulfonyl}urea

C16H14N4O3S (342.0786574)


   

4,4'-Dihydrazino-biphenyl

{4-hydrazinyl-[1,1-biphenyl]-4-yl}hydrazine

C12H14N4 (214.1218404)


   

2-(4-Phenylphenyl)acetohydrazide

2-{[1,1-biphenyl]-4-yl}acetohydrazide

C14H14N2O (226.1106074)


   

3,3'-Di-tert-butyl-5,5'-dimethoxybiphenyl-2,2'-diol

3,3-di-tert-butyl-5,5-dimethoxy-[1,1-biphenyl]-2,2-diol

C22H30O4 (358.214398)


   

2-([1,1'-Biphenyl]-2-yl)acetic acid

Biphenylylacetic acid, 14C-labeled

C14H12O2 (212.0837252)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

[1,1'-Biphenyl]-2-carboxamide

[1,1-Biphenyl]-2-carboxamide

C13H11NO (197.0840596)


   

3-Biphenylacetic acid

Biphenylylacetic acid, 14C-labeled

C14H12O2 (212.0837252)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Biphenyl-2,3-dicarboxylic acid

[1,1-biphenyl]-2,3-dicarboxylic acid

C14H10O4 (242.057906)


   

3-Aminobiphenyl

3-Aminobiphenyl

C12H11N (169.0891446)


   

3',4'-Dihydroxyflurbiprofen

2-{2-fluoro-3,4-dihydroxy-[1,1-biphenyl]-4-yl}propanoic acid

C15H13FO4 (276.079783)


   

2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid

2-((2-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1-biphenyl]-3-yl)oxy)acetic acid

C31H26N2O3 (474.19433260000005)


BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[1][2][3].

   

2',3-Dimethyl-4-aminobiphenyl

2,3-Dimethyl-4-aminobiphenyl hydrochloride

C14H15N (197.120443)


D009676 - Noxae > D002273 - Carcinogens

   

Felbinac

Goldshield brand OF 4-biphenylylacetic acid

C14H12O2 (212.0837252)


M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

4-Biphenylcarboxylic acid

4-Phenylbenzoic acid, potassium salt

C13H10O2 (198.06807600000002)


   

4-O-Methylhonokiol

2-[4-methoxy-3-(prop-2-en-1-yl)phenyl]-4-(prop-2-en-1-yl)phenol

C19H20O2 (280.146322)


4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research. 4-O-Methyl honokiol is a natural neolignan isolated from Magnolia officinalis, acts as a PPARγ agonist, and inhibtis NF-κB activity, used for cancer and inflammation research.

   

3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate

3-Carbamoyl-[1,1-biphenyl]-3-yl cyclohexylcarbamic acid

C20H22N2O3 (338.16303419999997)


URB-597 (KDS-4103) is an orally bioavailable and selective FAAH inhibitor. URB-597 inhibits FAAH activity with an IC50s of approximately 5 nM in rat brain membranes, 0.5 nM in intact rat neurons, 3 nM in human liver microsomes. Antidepressant-like effects. Analgesic activity[1].

   

Cyclohexyl biphenyl-3-ylcarbamate

cyclohexyl N-{[1,1-biphenyl]-3-yl}carbamate

C19H21NO2 (295.1572206)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   

4-Biphenylylacetic acid methyl ester

[1,1-BIPHENYL]-4-ACETIC ACID METHYL ESTER

C15H14O2 (226.09937440000002)


   

2-Dicyclohexylphosphino-2',6'-dimethoxybiphenyl

dicyclohexyl({2,6-dimethoxy-[1,1-biphenyl]-2-yl})phosphane

C26H35O2P (410.237454)


   

[1,1'-Biphenyl]-4,4'-dicarboxylic acid

[1,1-Biphenyl]-4,4-dicarboxylic acid

C14H10O4 (242.057906)


   

Dimethyl [1,1'-biphenyl]-4,4'-dicarboxylate

4,4-dimethyl [1,1-biphenyl]-4,4-dicarboxylate

C16H14O4 (270.0892044)


   

4-Hydroxy-3-(2'-hydroxy-[1,1'-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile

4-Hydroxy-3-(2-hydroxy-[1,1-biphenyl]-4-yl)-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carbonitrile

C20H12N2O3S (360.0568602000001)


   

Adomeglivant

3-({4-[1-({4-tert-butyl-2,6-dimethyl-[1,1-biphenyl]-4-yl}oxy)-4,4,4-trifluorobutyl]phenyl}formamido)propanoic acid

C32H36F3NO4 (555.2596292000001)


   

(4Z)-7-[(1S,2S,5R)-5-[([1,1'-Biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl]hept-4-enoic acid

(4Z)-7-[(1S,2S,5R)-5-[([1,1-Biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl]hept-4-enoic acid

C29H35NO5 (477.25151000000005)


   

Allisartan isoproxil

{[(propan-2-yloxy)carbonyl]oxy}methyl 2-butyl-4-chloro-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylate

C27H29ClN6O5 (552.1887854)


Allisartan isoproxil (ALS-3) is an orally potent, selective, non-peptide inhibitor of Angiotensin II Type 1. Allisartan isoproxil is also an antihypertensive agent. Allisartan isoproxil may inhibit angiotensin-aldosterone system and oxidative stress. Allisartan isoproxil lowers blood pressure and protects the organs, preventing cerebrovascular damage. Allisartan isoproxil (80-320 mg/kg/d) has shown toxicity in rat models by targeting liver organs[1][2].

   

Amarogentin

2-({4-ethenyl-8-oxo-3H,4H,4ah,5H,6H,8H-pyrano[3,4-c]pyran-3-yl}oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,3,5-trihydroxy-[1,1-biphenyl]-2-carboxylic acid

C29H30O13 (586.168633)


   

Anacetrapib

5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4-fluoro-2-methoxy-5-(propan-2-yl)-4-(trifluoromethyl)-[1,1-biphenyl]-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one

C30H25F10NO3 (637.1674659999999)


   

N-Hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)acetamide

N-Hydroxy2-[N-(propan-2-yloxy)[1,1-biphenyl]-4-sulphonamido]ethanimidic acid

C17H20N2O5S (364.10928700000005)


   

Atglistatin

1-[4-(dimethylamino)-[1,1-biphenyl]-3-yl]-3,3-dimethylurea

C17H21N3O (283.1684536)


Atglistatin is a selective adipose triglyceride lipase (ATGL) inhibitor which inhibits lipolysis with an IC50 of 0.7 μM in vitro.

   

Azilsartan

2-ethoxy-1-{[2-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid

C25H20N4O5 (456.143363)


   

Azilsartan medoxomil

(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate

C30H24N4O8 (568.1594064)


   

Batefenterol

GSK-961081;[1-[3-[2-chloro-4-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]methyl]-5-methoxyanilino]-3-oxopropyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate

C40H42ClN5O7 (739.2772611999999)


   

Bifeprunox

7-{4-[(3-phenylphenyl)methyl]piperazin-1-yl}-2,3-dihydro-1,3-benzoxazol-2-one

C24H23N3O2 (385.1790178)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

2-Biphenyl-4-yl-1-(1H-tetrazol-5-yl)ethylaminoethyl phosphonic acid

diphenyl {[(2-{[1,1-biphenyl]-4-yl}-1-(2H-1,2,3,4-tetrazol-5-yl)ethyl)amino]methyl}phosphonate

C28H26N5O3P (511.1773176000001)


   

(S)-2-Biphenyl-4-yl-1-(1H-tetrazol-5-yl)ethylaminomethyl phosphonic acid

{[(2-{[1,1-biphenyl]-4-yl}-1-(2H-1,2,3,4-tetrazol-5-yl)ethyl)amino]methyl}phosphonic acid

C16H18N5O3P (359.11472080000004)


   

Indoxam

2-{[3-({[1,1-biphenyl]-2-yl}methyl)-1-(carbamoylcarbonyl)-2-ethylindolizin-8-yl]oxy}acetic acid

C27H24N2O5 (456.1685134)


   

2-Amino-6-[2-[3-(3-methoxyphenyl)phenyl]ethyl]-3,6-dimethyl-5H-pyrimidin-4-one

2-amino-6-(2-{3-methoxy-[1,1-biphenyl]-3-yl}ethyl)-3,6-dimethyl-3,4,5,6-tetrahydropyrimidin-4-one

C21H25N3O2 (351.194667)


   

(4R,6S)-6-[(E)-2-[2-(4-Fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one

(4R,6S)-6-[(E)-2-[2-(4-Fluoro-3-methylphenyl)-4,6-dimethylphenyl]ethenyl]-4-hydroxyoxan-2-one

C22H23FO3 (354.16311399999995)


   

Darapladib

N-[2-(Diethylamino)ethyl]-2-(2-{[(4-fluorophenyl)methyl]sulphanyl}-4-oxo-1H,4H,5H,6H,7H-cyclopenta[D]pyrimidin-1-yl)-N-{[4-(trifluoromethyl)-[1,1-biphenyl]-4-yl]methyl}acetamide

C36H38F4N4O2S (666.2651456)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors Darapladib (SB-480848) is an orally active, selective and reversible Lp-PLA2 inhibitor (IC50=0.25 nM). Darapladib can trigger irreversible actions on glioma cell apoptosis and induce cycle arrest. Darapladib can be used in the study of atherosclerosis and cancer[1][2][3][4].

   

Dimethyl dimethoxy biphenyl

4,4-dimethoxy-2,3-dimethyl-1,1-biphenyl

C16H18O2 (242.1306728)


   

4-Ethyl-2-propyl-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylimidazole-5-carboxylic acid

4-ethyl-2-propyl-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid

C23H24N6O2 (416.19606439999995)


   

2-Propyl-4-pentafluoroethyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole-5-carboxylic acid

4-(1,1,2,2,2-pentafluoroethyl)-2-propyl-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid

C23H19F5N6O2 (506.1489574)


   

3-((2'-Carboxybiphenyl-4-yl)methyl)-2-cyclopropyl-7-methyl-3H-imidazo(4,5-b)pyridine

4-({2-cyclopropyl-7-methyl-3H-imidazo[4,5-b]pyridin-3-yl}methyl)-[1,1-biphenyl]-2-carboxylic acid

C24H21N3O2 (383.1633686)


   

Eltrombopag

3-{2-[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]diazen-1-yl}-2-hydroxy-[1,1-biphenyl]-3-carboxylic acid

C25H22N4O4 (442.1640972)


B - Blood and blood forming organs > B02 - Antihemorrhagics > B02B - Vitamin k and other hemostatics COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78275 - Agent Affecting Blood or Body Fluid Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Embusartan

Methyl 6-butyl-1-{[3-fluoro-2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-2-oxo-1,2-dihydropyridine-4-carboxylic acid

C25H24FN5O3 (461.18630859999996)


   

Encaleret

2-[1-(3-{[1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-yl]amino}-2-hydroxypropoxy)ethyl]-3-methyl-[1,1-biphenyl]-4-carboxylic acid

C29H33ClFNO4 (513.208202)


   

Erismodegib

N-[6-(2,6-Dimethylmorpholin-4-yl)pyridin-3-yl]-2-methyl-4-(trifluoromethoxy)-[1,1-biphenyl]-3-carboximidate

C26H26F3N3O3 (485.1926162000001)


   

Felbinac ethyl

Ethyl 2-{[1,1-biphenyl]-4-yl}acetic acid

C16H16O2 (240.1150236)


   

Fexaramine

3-[3-[[Cyclohexyl(oxo)methyl]-[[4-[4-(dimethylamino)phenyl]phenyl]methyl]amino]phenyl]-2-propenoate methyl ester

C32H36N2O3 (496.2725786)


   

Fimasartan

2-(2-butyl-4-methyl-6-oxo-1-{[2-(1H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide

C27H31N7OS (501.2310676)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist Fimasartan (BR-A-657) is a non-peptide antagonist of the angiotensin receptor AT1, used to study hypertension and heart failure.

   

Flurbiprofen axetil

1-(Acetyloxy)ethyl 2-{2-fluoro-[1,1-biphenyl]-4-yl}propanoic acid

C19H19FO4 (330.12673060000003)


   

Fradafiban

2-{5-[({4-carbamimidoyl-[1,1-biphenyl]-4-yl}oxy)methyl]-2-oxopyrrolidin-3-yl}acetic acid

C20H21N3O4 (367.15319860000005)


   

IODODIFLUNISAL

2,4-Difluoro-4-hydroxy-5-iodo-1,1-biphenyl-3-carboxylic acid

C13H7F2IO3 (375.9408006)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates

   

2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine

5-{2-[4-({2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl}methyl)phenyl]phenyl}-2H-1,2,3,4-tetrazole

C24H23N7 (409.2014838)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D057911 - Angiotensin Receptor Antagonists

   

N-[2-[4-[[3-Butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonyl-3-methyl-2-thiophenecarboxamide

N-{[4-({3-butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-4,5-dihydro-1H-1,2,4-triazol-4-yl}methyl)-[1,1-biphenyl]-2-yl]sulfonyl}-3-methylthiophene-2-carboxamide

C32H29F3N4O4S2 (654.158223)


   

Lefradafibanum

Methyl 2-(2-{[(4-{amino[(methoxycarbonyl)imino]methyl}-[1,1-biphenyl]-4-yl)oxy]methyl}-5-hydroxy-3,4-dihydro-2H-pyrrol-4-yl)acetic acid

C23H25N3O6 (439.174327)


   

Mibampator

N-{2-[4-(2-methanesulphonamidoethyl)-[1,1-biphenyl]-4-yl]propyl}propane-2-sulphonamide

C21H30N2O4S2 (438.16469)


   

3-((2'-(Benzoylaminosulfonyl)biphenyl-4-yl)methyl)-2-ethyl-5,7-dimethyl-3H-imidazo(4,5-b)pyridine

N-{[4-({2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl}methyl)-[1,1-biphenyl]-2-yl]sulfonyl}benzamide

C30H28N4O3S (524.1882018)


   

N,N,N',N'-TETRAMETHYLBENZIDINE

N4,N4,N4,N4-tetramethyl-[1,1-biphenyl]-4,4-diamine

C16H20N2 (240.16264)


   

Nitroflurbiprofen

4-(Nitrooxy)butyl 2-fluoro-alpha-methyl-(1,1-biphenyl)-4-acetic acid

C19H20FNO5 (361.13254420000004)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor

   

Olmesartan medoxomil

(5-Methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid

C29H30N6O6 (558.222672)


   

Pratosartan

2-propyl-3-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-3H,4H,5H,6H,7H,8H-cyclohepta[d]imidazol-4-one

C25H26N6O (426.2167986)


   

Ripisartan

5-methyl-7-propyl-8-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-2H,3H-[1,2,4]triazolo[1,5-c]pyrimidin-2-one

C23H22N8O (426.1916482)


   

Sacubitril

3-[(1-{[1,1-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl)-C-hydroxycarbonimidoyl]propanoate

C24H29NO5 (411.20456240000004)


   

Sacubitrilat

5-{[1,1-biphenyl]-4-yl}-4-[(3-carboxy-1-hydroxypropylidene)amino]-2-methylpentanoate

C22H25NO5 (383.173264)


   

Dimethyl 3,4-dimethoxy-6-phenylbenzene-1,2-dicarboxylate

2,3-Dimethyl 4,5-dimethoxy-[1,1-biphenyl]-2,3-dicarboxylic acid

C18H18O6 (330.11033280000004)


   

3-[2-Methoxy-4-[3-methoxy-4-(2-phenyl-1H-tetrazol-3-yl)phenyl]phenyl]-2-(4-nitrophenyl)-5-phenyl-1H-tetrazole

3-[3,3-dimethoxy-4-(2-phenyl-2,3-dihydro-1H-1,2,3,4-tetrazol-3-yl)-[1,1-biphenyl]-4-yl]-2-(4-nitrophenyl)-5-phenyl-2,3-dihydro-1H-1,2,3,4-tetrazole

C34H29N9O4 (627.2342394)


   

4-(1-(2-Fluoro-4-biphenyl)ethyl)-2-methylaminothiazole

4-(1-{2-fluoro-[1,1-biphenyl]-4-yl}ethyl)-N-methyl-1,3-thiazol-2-amine

C18H17FN2S (312.10964140000004)


   

Ethyl 5-[[[4-(3-methylsulfonylphenyl)phenyl]methyl-(2,4,6-trimethylphenyl)sulfonylamino]methyl]furan-2-carboxylate

Ethyl 5-{[N-({3-methanesulphonyl-[1,1-biphenyl]-4-yl}methyl)2,4,6-trimethylbenzenesulphonamido]methyl}furan-2-carboxylic acid

C31H33NO7S2 (595.1698348000001)


   

TUG-891

3-(4-((4-Fluoro-4-methyl-(1,1-biphenyl)-2-yl)methoxy)phenyl)propanoic acid

C23H21FO3 (364.14746479999997)


   

1-(4-Biphenylyl)-4(S)-hydroxy-5(S)-2,5-bis((N-(methoxycarbonyl-)-L-tert-leucinyl)amino)-6-phenyl-2-azahexane

N-{4-[({[1,1-biphenyl]-4-yl}methyl)[(1-hydroxy-2-{[hydroxy(methoxy)methylidene]amino}-3,3-dimethylbutylidene)amino]amino]-3-hydroxy-1-phenylbutan-2-yl}-2-{[hydroxy(methoxy)methylidene]amino}-3,3-dimethylbutanimidate

C39H53N5O7 (703.3944787999999)


   

2-Ethyl-5,7-dimethyl-3-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]imidazo[4,5-b]pyridine

5-(4-{2-ethyl-5,7-dimethyl-3H-imidazo[4,5-b]pyridin-3-yl}-[1,1-biphenyl]-2-yl)-2H-1,2,3,4-tetrazole

C23H21N7 (395.1858346)


D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D057911 - Angiotensin Receptor Antagonists

   

VAPIPROST

7-[5-({[1,1-biphenyl]-4-yl}methoxy)-3-hydroxy-2-(piperidin-1-yl)cyclopentyl]hept-4-enoic acid

C30H39NO4 (477.28789340000003)


   

ZD-7155

5,7-Diethyl-1-(2-(1H-1,2,3,4-tetrahydrazol-5-yl)biphenyl-4-methyl)-1,2,3,4-tetrahydro-1,6-naphthyridin-2-one hydrochloride

C26H26N6O (438.2167986)


D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers

   

[2-(Pyridin-2-ylmethyl)-4-(4-sulfooxyphenyl)phenyl] hydrogen sulfate

{3-[(pyridin-2-yl)methyl]-4-(sulphooxy)-[1,1-biphenyl]-4-yl}oxidanesulphonic acid

C18H15NO8S2 (437.023907)


   

N-[2-[4-[[3-Butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonyl-5-methylthiophene-2-carboxamide

N-{[4-({3-butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-4,5-dihydro-1H-1,2,4-triazol-4-yl}methyl)-[1,1-biphenyl]-2-yl]sulphonyl}-5-methylthiophene-2-carboxamide

C32H29F3N4O4S2 (654.158223)


   

3-Phenyl benzaldehyde

3-Phenyl benzaldehyde

C13H10O (182.073161)


3-phenyl benzaldehyde belongs to biphenyls and derivatives class of compounds. Those are organic compounds containing to benzene rings linked together by a C-C bond. 3-phenyl benzaldehyde is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 3-phenyl benzaldehyde can be found in ginger, which makes 3-phenyl benzaldehyde a potential biomarker for the consumption of this food product.

   

4-Phenylbenzaldehyde

4-Phenylbenzaldehyde

C13H10O (182.073161)


4-phenylbenzaldehyde belongs to biphenyls and derivatives class of compounds. Those are organic compounds containing to benzene rings linked together by a C-C bond. 4-phenylbenzaldehyde is practically insoluble (in water) and an extremely weak basic (essentially neutral) compound (based on its pKa). 4-phenylbenzaldehyde can be found in ginger, which makes 4-phenylbenzaldehyde a potential biomarker for the consumption of this food product.

   

3-2-carboxyphenylcatechol

2-Carboxy-2-hydroxy-[1,1-biphenyl]-3-olic acid

C13H9O4 (229.05008139999998)


3-2-carboxyphenylcatechol is also known as cpc. 3-2-carboxyphenylcatechol is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 3-2-carboxyphenylcatechol can be found in a number of food items such as rocket salad (sspecies), winter squash, garlic, and okra, which makes 3-2-carboxyphenylcatechol a potential biomarker for the consumption of these food products.

   

buddlenol E

(2E)-3-{2,6-dihydroxy-3,5-dimethoxy-5-[(1E)-3-oxobut-1-en-1-yl]-[1,1-biphenyl]-3-yl}prop-2-enoic acid

C21H20O7 (384.120897)


   

Pemigatinib

11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-[(morpholin-4-yl)methyl]-5,7,11,13-tetraazatricyclo[7.4.0.0^{2,6}]trideca-1,3,6,8-tetraen-12-one

C24H27F2N5O4 (487.2031006000001)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor

   

Tazemetostat

N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-4-methyl-4-[(morpholin-4-yl)methyl]-[1,1-biphenyl]-3-carboxamide

C34H44N4O4 (572.3362384)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS